Halozyme Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.9M | 96k | 40.68 |
| 2023-12-31 | $2.6M | 71k | 36.96 |
| 2023-09-30 | $3.0M | 77k | 38.20 |
| 2023-06-30 | $2.8M | 78k | 36.07 |
| 2023-03-31 | $4.1M | 107k | 38.19 |
| 2022-12-31 | $5.9M | 104k | 56.90 |
| 2022-09-30 | $3.0M | 75k | 39.54 |
| 2022-06-30 | $1.8M | 42k | 44.00 |
| 2022-03-31 | $1.3M | 33k | 39.88 |
| 2021-12-31 | $2.1M | 51k | 40.22 |
| 2021-09-30 | $1.4M | 35k | 40.69 |
| 2021-06-30 | $1.6M | 36k | 45.41 |
| 2021-03-31 | $1.3M | 30k | 41.67 |
| 2020-12-31 | $2.1M | 48k | 42.70 |
| 2020-09-30 | $803k | 31k | 26.27 |
| 2020-06-30 | $607k | 23k | 26.81 |
| 2020-03-31 | $396k | 22k | 18.00 |
| 2019-12-31 | $422k | 24k | 17.72 |
| 2019-09-30 | $368k | 24k | 15.51 |
| 2018-09-30 | $272k | 15k | 18.15 |
| 2018-06-30 | $222k | 13k | 16.88 |
| 2017-12-31 | $216k | 11k | 20.22 |
| 2016-09-30 | $142k | 12k | 12.06 |
| 2016-06-30 | $101k | 12k | 8.65 |
| 2016-03-31 | $113k | 12k | 9.44 |
| 2015-12-31 | $207k | 12k | 17.29 |
| 2015-09-30 | $223k | 17k | 13.46 |
| 2015-06-30 | $366k | 16k | 22.59 |
| 2015-03-31 | $432k | 30k | 14.28 |
| 2014-12-31 | $264k | 27k | 9.64 |
| 2014-09-30 | $216k | 24k | 9.11 |
| 2014-06-30 | $219k | 22k | 9.86 |
| 2014-03-31 | $208k | 16k | 12.68 |
| 2013-12-31 | $240k | 16k | 15.00 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates